<code id='02B53C799E'></code><style id='02B53C799E'></style>
    • <acronym id='02B53C799E'></acronym>
      <center id='02B53C799E'><center id='02B53C799E'><tfoot id='02B53C799E'></tfoot></center><abbr id='02B53C799E'><dir id='02B53C799E'><tfoot id='02B53C799E'></tfoot><noframes id='02B53C799E'>

    • <optgroup id='02B53C799E'><strike id='02B53C799E'><sup id='02B53C799E'></sup></strike><code id='02B53C799E'></code></optgroup>
        1. <b id='02B53C799E'><label id='02B53C799E'><select id='02B53C799E'><dt id='02B53C799E'><span id='02B53C799E'></span></dt></select></label></b><u id='02B53C799E'></u>
          <i id='02B53C799E'><strike id='02B53C799E'><tt id='02B53C799E'><pre id='02B53C799E'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:57
          A dosage of Wegovy, a drug used for weight loss
          Amanda Andrade-Rhoades/AP

          U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

          The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

          advertisement

          The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Biotech execs pursue obesity drug boom: ‘It’s the early innings’
          Biotech execs pursue obesity drug boom: ‘It’s the early innings’

          ElaineChenofSTAT,upperleft,talkedaboutobesitydrugswith,clockwise,RaymondStevenofStructureTherapeutic

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          The dental labor crisis is a moment of opportunity

          Aregistereddentalhygienistcleansapatient'steethatacommunityhealthcenter.JohnMoore/GettyImagesWhilest